SCHEMBL6948352

SCHEMBL6948352

CCCOc1nc(C)nc(N2CCc3ccccc3CC2)c1C#N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
KDM4E B2RXH2 8/20 0.46
MAPT P10636 8/20 0.46
HPGD P15428 6/20 0.46
APAF1 O14727 1/20 0.41
CASP3 P42574 1/20 0.41
CASP6 P55212 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
HSD17B10 Q99714 5/20 0.41
MAPK1 P28482 3/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HTT P42858 4/20 0.41
TP53 P04637 2/20 0.41
CXCR4 P61073 2/20 0.40
POLB P06746 2/20 0.37
TSHR P16473 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957783 0.91 HRH4 (0.44) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6947782 0.90 CXCR4 (0.41) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6951193 0.87 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6956303 0.85 KDM4E (0.41) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6947498 0.85 CXCR4 (0.43) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6952068 0.84 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6953136 0.82 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6945186 0.82 MEN1 (0.38) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6945190 0.82 MEN1 (0.38) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL6950038 0.81 KDM4E (0.41) ALDH1A1KDM4EMAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed